BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2012
View Archived Issues
Scientists discover new biomarker of oral squamous cell carcinoma
Read More
RNAi screen identifies targets for diseases involving protein misfolding
Read More
Alnylam provides update on pipeline goals for 2012
Read More
Achillion provides new clinical data on protease inhibitors for hepatitis C
Read More
Spanish study reveals novel potential biomarker of CCL
Read More
Phase III data disclosed on Technosphere Insulin versus usual care for diabetes
Read More
Novartis discovers new pan-Trk kinase inhibitor
Read More
Novo Nordisk presents new analogues of fibroblast growth factor 21
Read More
Korean university researchers disclose novel glycolipid derivatives
Read More
Pfizer prepares new agents for hepatitis C virus infection
Read More
Evotec achieves milestone for oncology product from Boehringer Ingelheim
Read More
Phase I study of CB-625 scheduled to begin this quarter
Read More
NovoMedix patents new eIF4E inhibitors for cancer
Read More
Novel chemokine CCR2 receptor antagonists synthesized by Janssen Pharmaceutica
Read More
DFH Pharma and NCI enter collaboration
Read More
Hospira kicks off enrollment in phase III program of biosimilar EPO
Read More
Sinovac begins phase III study of EV 71 vaccine
Read More
New leptin fusion proteins patented by AngioChem
Read More
Polaris begins dosing in ADI-PEG 20/docetaxel combination study
Read More
FDA clears Immuron's IND for phase IIb study in NASH/fatty liver
Read More
Dosing starts in phase IIa study of Pharmos' levotofisopam
Read More
Companies to collaborate on shark antibody technology
Read More
Hemispherx receives extension to modify NDA
Read More
Intercell and SSI announce start of phase II trial of tuberculosis vaccine candidate
Read More
Starpharma reaches agreement with FDA on phase III VivaGel studies
Read More